Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-13
1998-09-01
Grumbling, Matthew V.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514318, 514325, 514320, 514324, 546195, 546196, 546198, 546202, 546256, 546262, 546263, 546265, 544361, 544375, 544386, 544389, 544390, 544399, 544401, A61K 31495, A61K 31505, C07D40314, C07D40114
Patent
active
058011757
ABSTRACT:
Novel compounds of Formula ##STR1## are disclosed. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering a compound of the above formula to a biological system. In particular, the method inhibits the abnormal growth of cells in a mammal such as a human being.
REFERENCES:
patent: 4144337 (1979-03-01), Bastian
patent: 4282233 (1981-08-01), Villani
patent: 4826853 (1989-05-01), Piwinski et al.
patent: 4831042 (1989-05-01), Villani
patent: 4863981 (1989-09-01), Schumacher et al.
patent: 5089496 (1992-02-01), Piwinski et al.
patent: 5104876 (1992-04-01), Piwinski et al.
patent: 5141851 (1992-08-01), Brown et al.
patent: 5151423 (1992-09-01), Piwinski et al.
patent: 5185248 (1993-02-01), Barbacid et al.
patent: 5204348 (1993-04-01), Fukazawa et al.
patent: 5393890 (1995-02-01), Syojii et al.
patent: 5405843 (1995-04-01), Fukazawa et al.
Cell, 65, 1-4 (1991).
J. Biol. Chem., 266, (24) 15575-15578 (1991).
Proc. Natl. Acad. Sci. USA, 87, 3042-3046 (1990).
Proc. Natl. Acad. Sci. USA, 88, 8631-8635 (1991).
Nature, 356, 713-715 (1992).
Proc. Natl. Acad. Sci. USA. 87, 7541-7545 (1990).
J. Biol. Chem., 265, (25) 14701-14704 (1990).
Proc. Natl. Acad. Sci. USA, 87, 7926-7929 (1990).
Cell, 62, 81-88 (1990).
Biochemistry, 31, 3800-3807.
Science, 260 (1993), 1934-1937.
Science, 260 (1993), 1937-1942.
Piwinski, et al., J. Med. Chem., 34, (1) 457-461 (1991).
Chem. Abtracts No. 121:53129x (1994) for WO94/04561.
Masci, J. Chem. Soc. Chem. Commun., 1262-1263 (1982).
Masci, J. Org. Chem., 50, 4081-4087 (1985).
Sebti, et al., Proc. Ann. Meeting AM Assoc. Cancer Res., 33:A2217 (1992).
Villani, et al., J. Med. Chem., 15, (7) 750-754 (1972).
Billah, et al., Lipids, 26, (12) 1172-1174 (1991).
Villani, et al., Arzneim.-Forsch./Drug Res., 36(II), 1311-1314 (1986).
Yokoyama et al, Proc. Natl. Acad. Sci. USA, 88, 5302-5306 (1991).
Omer et al, Biochemistry, 32, 5167-5176 (1993).
Furth et al, J. Virology, 43, 294-304 (1982).
Price et al, Proc. Natl. Acad. Sci. USA, 84, 156-160 (1987).
Chemical Abstracts, 121 (1994) 301326v, abstract for DN.
Khosravi-Far et al, Cell Growth & Differentiation, 3, 461-469 (1992).
Advanced Organic Chemistry, 3rd ed., Part B: Reactions and Synthesis (1990), 571-573.
Sarges, et al, J. Med. Chem., 33, 1859-1865 (1990).
Graham, Exp. Opin. Ther. Patents, 5, 1269-1285 (1995).
Afonso Adriano
Baldwin John J.
Doll Ronald J.
Li Ge
Mallams Alan K.
Grumbling Matthew V.
Jeanette Henry C.
Pharmacopeia Inc.
Schering Corporation
Thompson Paul
LandOfFree
Tricyclic compounds useful for inhibition of G-protein function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic compounds useful for inhibition of G-protein function , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic compounds useful for inhibition of G-protein function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-270501